loading
Schlusskurs vom Vortag:
$1.11
Offen:
$1.11
24-Stunden-Volumen:
146.27K
Relative Volume:
0.39
Marktkapitalisierung:
$18.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.24M
KGV:
-1.4445
EPS:
-0.7615
Netto-Cashflow:
$-4.79M
1W Leistung:
-5.17%
1M Leistung:
-5.98%
6M Leistung:
-44.44%
1J Leistung:
+1.85%
1-Tages-Spanne:
Value
$1.10
$1.13
1-Wochen-Bereich:
Value
$1.10
$1.18
52-Wochen-Spanne:
Value
$0.51
$5.01

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name
Firmenname
Mira Pharmaceuticals Inc
Name
Telefon
813-369-5150
Name
Adresse
1200 BRICKELL AVENUE, MIAMI
Name
Mitarbeiter
6
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MIRA's Discussions on Twitter

Vergleichen Sie MIRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MIRA
Mira Pharmaceuticals Inc
1.10 18.22M 0 -11.24M -4.79M -0.7615
Drug Manufacturers - General icon
LLY
Lilly Eli Co
873.68 830.35B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
88.08 390.99B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
ABBV
Abbvie Inc
202.08 356.74B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
162.30 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
MRK
Merck Co Inc
89.50 251.88B 64.17B 17.12B 14.84B 6.7297

Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten

pulisher
Feb 07, 2025

Microstrategy Inc. – 8% PRF PERPETUAL USD 100 – Ser A’s (STRK) Stock: A Week-by-Week Analysis - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Monday.Com Ltd (MNDY) Shares Down Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Mira Pharmaceuticals Inc (MIRA) Stock: Evaluating the Market Performance - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Vanda Pharmaceuticals Inc (VNDA) Shares Rise Despite Market Challenges - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Air Transport Services Group Inc (ATSG) Stock: Evaluating the Market Performance - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Report: OpenAI's ex-CTO, Mira Murati, has recruited OpenAI co-founder John Schulman - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

OpenAI cofounder John Schulman is joining Mira Murati’s startup after brief stint at Anthropic - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

Kernel and Mira Launch Industry’s First $300M Secured AI API - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Feb 03, 2025

Mira Network Launches $10M Grant Program for AI Builders - EIN News

Feb 03, 2025
pulisher
Jan 31, 2025

UCalgary researchers to validate Mira Hormone Monitor - Yahoo Finance

Jan 31, 2025
pulisher
Jan 30, 2025

TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com

Jan 30, 2025
pulisher
Jan 28, 2025

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 27, 2025

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 25, 2025

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 15, 2025

Wealth Enhancement Advisory Services LLC Acquires 6,454 Shares of PPL Co. (NYSE:PPL) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World

Jan 15, 2025
pulisher
Jan 07, 2025

AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com

Jan 07, 2025
pulisher
Jan 05, 2025

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance

Jan 05, 2025
pulisher
Dec 31, 2024

Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha

Dec 31, 2024
pulisher
Dec 30, 2024

Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha

Dec 30, 2024
pulisher
Dec 23, 2024

Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World

Dec 23, 2024
pulisher
Dec 22, 2024

Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa

Dec 22, 2024
pulisher
Dec 21, 2024

Mira Pharmaceuticals appoints new accounting firm - Investing.com

Dec 21, 2024
pulisher
Dec 21, 2024

Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

Should You Buy Joby Aviation Stock While It's Below $10? - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart

Dec 21, 2024
pulisher
Dec 21, 2024

MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

Stocks In Play: Canacol Energy Ltd. - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Grain Spreads: Profit Taking Theme - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Stocks Rally On Dovish PCE Inflation Report - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

The Current State Of HR Is Unacceptable - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Is W.R. Berkley Stock Outperforming The Dow? - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart

Dec 20, 2024
pulisher
Dec 20, 2024

Is PPG Industries Stock Underperforming The S&P 500? - Barchart

Dec 20, 2024

Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Mira Pharmaceuticals Inc-Aktie (MIRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Aminov Erez
Chief Executive Officer
Nov 20 '24
Sale
1.27
44,590
56,629
1,061,200
drug_manufacturers_general SNY
$54.46
price up icon 0.61%
$109.95
price down icon 0.07%
drug_manufacturers_general PFE
$26.30
price up icon 1.54%
$303.01
price up icon 1.71%
drug_manufacturers_general NVS
$109.35
price up icon 1.90%
drug_manufacturers_general MRK
$89.50
price up icon 2.08%
Kapitalisierung:     |  Volumen (24h):